Clinical Trial Update: Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating hyperbaric oxygen therapy for treating post-COVID-19 symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-covid Syndrome
• Post-covid-19 Condition
• Post-covid-19 Syndrome

Drugs mentioned

• Hyperbaric Oxygen Therapy

Snippet

Sponsor: Erasmus Medical Center | Conditions: Post-COVID-19 Syndrome, Post-COVID Syndrome | Phase 3 | Status: UNKNOWN